Clinical outcomes in a cohort of patients with T1 high grade urothelial bladder cancer not receiving intravesical bacillus Calmette-Guerin: a 15 year experience

Ceylon Med J. 2018 Mar 31;63(1):37-39. doi: 10.4038/cmj.v63i1.8626.
No abstract available

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • BCG Vaccine / therapeutic use
  • Carcinoma in Situ / drug therapy
  • Carcinoma in Situ / mortality*
  • Carcinoma in Situ / pathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Outcome Assessment, Health Care
  • Prospective Studies
  • Retrospective Studies
  • Survival Rate
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / mortality*
  • Urinary Bladder Neoplasms / pathology

Substances

  • BCG Vaccine